Participant's hypothetical treatment choice of either palliative care or intensive care. Participants are told: "If the child was actually born shortly after the conversation described above, which treatment would you prefer if you were in this situation?" and given the options of "Palliative care treatment" or "Intensive care treatment". This variable is assessed for the frequency of each option chosen.
Group
Value
95% CI
Text-only Outcome Data, 30% Survival
130
Text-only Outcome Data, 60% Survival
135
Static Pictograph Outcome Data, 30% Survival
143
Static Pictograph Outcome Data, 60% Survival
126
Iterative Pictograph Outcome Data, 30% Survival
129
Iterative Pictograph Outcome Data, 60% Survival
123
Text-only Outcome Data, 30% Survival
46
Text-only Outcome Data, 60% Survival
42
Static Pictograph Outcome Data, 30% Survival
36
Static Pictograph Outcome Data, 60% Survival
51
Iterative Pictograph Outcome Data, 30% Survival
47
Iterative Pictograph Outcome Data, 60% Survival
44
Values: Quality of Life or Sanctity of LifeSecondary· Assessed post-intervention, immediately after treatment choice.
Participants answered the following: "In making end-of-life decisions: 1) Quality of life is much more important than preserving life, 2) Quality of life is somewhat more important than preserving life, 3) Preserving life is somewhat more important than quality of life, or 4) Preserving life is much more important than quality of life." In the range of 1-4, a score of 4 indicated the greatest participant value of sanctity of life.
Group
Value
95% CI
Text-only Outcome Data, 30% Survival
80
Text-only Outcome Data, 60% Survival
90
Static Pictograph Outcome Data, 30% Survival
85
Static Pictograph Outcome Data, 60% Survival
93
Iterative Pictograph Outcome Data, 30% Survival
90
Iterative Pictograph Outcome Data, 60% Survival
78
Text-only Outcome Data, 30% Survival
42
Text-only Outcome Data, 60% Survival
45
Static Pictograph Outcome Data, 30% Survival
42
Static Pictograph Outcome Data, 60% Survival
47
Iterative Pictograph Outcome Data, 30% Survival
38
Iterative Pictograph Outcome Data, 60% Survival
44
Text-only Outcome Data, 30% Survival
31
Text-only Outcome Data, 60% Survival
26
Static Pictograph Outcome Data, 30% Survival
30
Static Pictograph Outcome Data, 60% Survival
21
Iterative Pictograph Outcome Data, 30% Survival
31
Iterative Pictograph Outcome Data, 60% Survival
26
Text-only Outcome Data, 30% Survival
23
Text-only Outcome Data, 60% Survival
16
Static Pictograph Outcome Data, 30% Survival
22
Static Pictograph Outcome Data, 60% Survival
16
Iterative Pictograph Outcome Data, 30% Survival
17
Iterative Pictograph Outcome Data, 60% Survival
19
Preference for Medical AutonomySecondary· Assessed post-intervention, immediately after treatment choice
Participants were asked on a 4-point scale their medical autonomy preferences, in the form of: "In making medical decisions... 1) I always prefer to have the doctor make medical decisions for me. 2) I would prefer to have the doctor make medical decisions for me most of the time. 3) I would prefer to make my own medical decisions most of the time. 4) I always prefer to make my own decisions."
Group
Value
95% CI
Text-only Outcome Data, 30% Survival
36
Text-only Outcome Data, 60% Survival
49
Static Pictograph Outcome Data, 30% Survival
46
Static Pictograph Outcome Data, 60% Survival
42
Iterative Pictograph Outcome Data, 30% Survival
53
Iterative Pictograph Outcome Data, 60% Survival
48
Text-only Outcome Data, 30% Survival
43
Text-only Outcome Data, 60% Survival
55
Static Pictograph Outcome Data, 30% Survival
44
Static Pictograph Outcome Data, 60% Survival
58
Iterative Pictograph Outcome Data, 30% Survival
44
Iterative Pictograph Outcome Data, 60% Survival
35
Text-only Outcome Data, 30% Survival
64
Text-only Outcome Data, 60% Survival
41
Static Pictograph Outcome Data, 30% Survival
53
Static Pictograph Outcome Data, 60% Survival
49
Iterative Pictograph Outcome Data, 30% Survival
46
Iterative Pictograph Outcome Data, 60% Survival
60
Text-only Outcome Data, 30% Survival
33
Text-only Outcome Data, 60% Survival
32
Static Pictograph Outcome Data, 30% Survival
36
Static Pictograph Outcome Data, 60% Survival
28
Iterative Pictograph Outcome Data, 30% Survival
33
Iterative Pictograph Outcome Data, 60% Survival
24
Subjective Sense of ProbabilitySecondary· Assessed post-intervention, immediately after treatment choice.
After reporting an objective value of the probability of survival that has been described to them in the vignette and intervention, participants report their subjective sense of probability.
Specifically, they will read: "Assume again that your baby was born prematurely at 22 weeks and given intensive care treatment. The doctor gave you the same information you read earlier. At a gut level, what would you believe is your own baby's actual chance of survival? Please click somewhere along the bar below to indicate your response." Participants use a slider scale below the item to respond from "N
Group
Value
95% CI
Text-only Outcome Data, 30% Survival
61.5
± 29.9
Text-only Outcome Data, 60% Survival
66.1
± 25.0
Static Pictograph Outcome Data, 30% Survival
64.8
± 27.7
Static Pictograph Outcome Data, 60% Survival
65.4
± 25.9
Iterative Pictograph Outcome Data, 30% Survival
65.7
± 26.7
Iterative Pictograph Outcome Data, 60% Survival
62.7
± 26.0
Sponsor's own description
Women recruited from the internet will be put in a hypothetical situation of being in labor at 22 weeks of pregnancy, and presented with information on the likelihood of survival and chance of disability for babies born at this gestational age.
Participants will be randomized to receive this outcome data in one of three formats: as text-only, in a static pictograph, or in an iterative pictograph. Participants will also be randomized to seeing the chance of survival as 30% or 60%.
Participants were then asked to choose between comfort care and intensive care in this situation. Participants' religiosity, value of the sanctity of life, and health literacy were also assessed.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07490912 — Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/o
· recruiting
NCT07183462 — Azithromycin and Ampicillin for Late PPROM
· Phase 4
· recruiting
NCT07306793 — The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body We
· NA
· recruiting
NCT06554522 — Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa
· Phase 4
· recruiting
NCT06340971 — Air Pollution and Pregnancy
· recruiting
Other Medical College of Wisconsin trials
Trials by the same sponsor.
NCT07260552 — Rapid Engagement for Solutions to Population and Outcomes Through Networked Dialogue for Coronary Heart Disease
· not yet recruiting
NCT06795360 — Weight Changes After Incretin-mimetics
· NA
· not yet recruiting
NCT07228208 — Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes
· NA
· not yet recruiting
NCT07298460 — Stimulation-based Therapy to Improve Balance in DCM
· Phase 1, PHASE2
· not yet recruiting
NCT07434544 — Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical College of Wisconsin
Last refreshed: 24 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04859114.